Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

PHASE2UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2018

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
PROCEDURE

Multiple Sclerosis Functional Composite

The MSFC is a diagnostic test that measures multiple sclerosis symptoms. It includes a timed walk test, 9-hole peg test, and paced auditory serial addition test. The MSFC is administered in-person at the study site.

PROCEDURE

Mobile Multiple Sclerosis Functional Composite

The mMSFC is a diagnostic test that measures multiple sclerosis symptoms from. It includes a timed walk test, 9-hole peg test, and paced auditory serial addition test. All aspects of this exam are completed from a participant's home using remote sensing technology and video conferencing.

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

Sponsors
All Listed Sponsors
lead

Transparency Life Sciences

INDUSTRY

NCT02369926 - Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis | Biotech Hunter | Biotech Hunter